RNAC
Price
$11.85
Change
+$0.22 (+1.89%)
Updated
Apr 24, 02:45 PM (EDT)
Capitalization
301.56M
SNPX
Price
$2.30
Change
+$0.03 (+1.32%)
Updated
Apr 24, 10:38 AM (EDT)
Capitalization
2.84M
Ad is loading...

RNAC vs SNPX

Header iconRNAC vs SNPX Comparison
Open Charts RNAC vs SNPXBanner chart's image
Cartesian Therapeutics
Price$11.85
Change+$0.22 (+1.89%)
Volume$196
Capitalization301.56M
Synaptogenix
Price$2.30
Change+$0.03 (+1.32%)
Volume$100
Capitalization2.84M
RNAC vs SNPX Comparison Chart
Loading...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNAC vs. SNPX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNAC is a Buy and SNPX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (RNAC: $11.64 vs. SNPX: $2.27)
Brand notoriety: RNAC and SNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNAC: 49% vs. SNPX: 106%
Market capitalization -- RNAC: $301.56M vs. SNPX: $2.84M
RNAC [@Biotechnology] is valued at $301.56M. SNPX’s [@Biotechnology] market capitalization is $2.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNAC’s FA Score shows that 0 FA rating(s) are green whileSNPX’s FA Score has 2 green FA rating(s).

  • RNAC’s FA Score: 0 green, 5 red.
  • SNPX’s FA Score: 2 green, 3 red.
According to our system of comparison, SNPX is a better buy in the long-term than RNAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNAC’s TA Score shows that 6 TA indicator(s) are bullish.

  • RNAC’s TA Score: 6 bullish, 2 bearish.

Price Growth

RNAC (@Biotechnology) experienced а +10.12% price change this week, while SNPX (@Biotechnology) price change was +1.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

RNAC is expected to report earnings on Mar 13, 2025.

SNPX is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($302M) has a higher market cap than SNPX($2.84M). SNPX (-34.599) and RNAC (-35.008) have similar YTD gains . SNPX has higher annual earnings (EBITDA): -6.76M vs. RNAC (-75.99M). RNAC has more cash in the bank: 213M vs. SNPX (22.1M). RNAC has higher revenues than SNPX: RNAC (38.9M) vs SNPX (0).
RNACSNPXRNAC / SNPX
Capitalization302M2.84M10,630%
EBITDA-75.99M-6.76M1,124%
Gain YTD-35.008-34.599101%
P/E RatioN/A2.75-
Revenue38.9M0-
Total Cash213M22.1M964%
Total Debt14MN/A-
FUNDAMENTALS RATINGS
RNAC: Fundamental Ratings
RNAC
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RNAC
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ERSTX23.75N/A
N/A
Eaton Vance Large-Cap Value R
GCVIX21.73N/A
N/A
Goldman Sachs Large Cp Val Insghts Instl
LIORX11.12N/A
N/A
ClearBridge International Value R
FAPMX12.19N/A
N/A
Fidelity Advisor Healthy Future I
MRGRX49.24N/A
N/A
MFS Core Equity I

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with SNPX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
+3.37%
SNPX - RNAC
91%
Closely correlated
+8.28%
ALLR - RNAC
86%
Closely correlated
+1.93%
NRXP - RNAC
86%
Closely correlated
+3.66%
PALI - RNAC
81%
Closely correlated
+2.71%
HRTX - RNAC
39%
Loosely correlated
+2.33%
More

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
+8.28%
NCNA - SNPX
92%
Closely correlated
+14.09%
RNAC - SNPX
91%
Closely correlated
+3.37%
AGEN - SNPX
91%
Closely correlated
-0.70%
ALLR - SNPX
87%
Closely correlated
+1.93%
NRXP - SNPX
84%
Closely correlated
+3.66%
More